グローバル・多嚢胞性卵巣症候群(PCOS)治療薬市場動向(2014-2018)...市場調査レポートについてご紹介

【英文タイトル】Global PCOS Drugs Market 2014-2018

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
Product Profiles
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Competitive Analysis of Marketed Products
08. Pipeline Snapshot
09. Rate of Incidence and Prevalence
09.1.1 Americas
09.1.2 Europe
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Vendors Analysis 2013
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Sanofi SA
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Business Segmentation
19.1.4 Revenue by Business Segmentation
19.1.5 Revenue Comparison 2012 and 2013
19.1.6 Sales by Geography
19.1.7 Business Strategy
19.1.8 Key Developments
19.1.9 SWOT Analysis
19.1.10 Strengths
19.1.11 Weakness
19.1.12 Opportunities
19.1.13 Threats
19.2 Bristol Myers Squibb Co.
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Key Product Offerings
19.2.4 Sales by Geography
19.2.5 Business Strategy
19.2.6 Key Information
19.2.7 SWOT Analysis
19.2.8 Strengths
19.2.9 Weaknesses
19.2.10 Opportunities
19.2.11 Threats
19.3 Novartis A.G.
19.3.1 Key Facts
19.3.2 Business Description
19.3.3 Business Segmentation
19.3.4 Revenue by Business Segmentation
19.3.5 Revenue Comparison 2012 and 2013
19.3.6 Sales by Geography
19.3.7 Business Strategy
19.3.8 Key Developments
19.4 SWOT Analysis
19.4.1 Strengths
19.4.2 Weaknesses
19.4.3 Opportunities
19.4.4 Threats
19.5 Teva Pharmaceutical Inc.
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation
19.5.4 Revenue by Business Segmentation
19.5.5 Revenue Comparison 2012 and 2013
19.5.6 Revenue Segmentation by Geography
19.5.7 Business Strategy
19.5.8 Key Developments
19.5.9 SWOT Analysis
19.5.10 Strengths
19.5.11 Weakness
19.5.12 Opportunities
19.5.13 Threats
19.6 Merck & Co. Inc.
19.6.1 Key Facts
19.6.2 Business Description
19.6.3 Business Segmentation
19.6.4 Revenue by Business Segmentation
19.6.5 Revenue Comparison 2012 and 2013
19.6.6 Sales by Geography
19.6.7 Business Strategy
19.6.8 Key Developments
19.6.9 SWOT Analysis
19.6.10 Strengths
19.6.11 Weaknesses
19.6.12 Opportunities
19.6.13 Threats
20. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global PCOS Drugs Market 2013-2018 (US$ million)
Exhibit 3: Global PCOS Drugs Market by Geographical Segmentation 2013
Exhibit 4: Sanofi SA: Business Segmentation
Exhibit 5: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 6: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 7: Sanofi SA: Sales Revenue by Geographical Segmentation 2013
Exhibit 8: Bristol-Myers Squibb Co.: Key Product Offerings (Based on Therapeutic Areas)
Exhibit 9: Bristol-Myers Squibb Co.: Sales by Geographical Segmentation 2013
Exhibit 10: Novartis AG: Business Segmentation
Exhibit 11: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 12: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 13: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 14: Teva Pharmaceutical Industries Ltd.: Business Segmentation
Exhibit 15: Teva Pharmaceutical Industries Ltd.: Revenue by Business Segmentation 2013
Exhibit 16: Teva Pharmaceutical Industries Ltd.: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 17: Teva Pharmaceutical Industries Ltd.: Revenue by Geographical Segmentation 2013
Exhibit 18: Merck & Co. Inc.: Business Segmentation 2013
Exhibit 19: Merck & Co. Inc.: Revenue by Business Segmentation 2013
Exhibit 20: Merck & Co. Inc.: Revenue by Business Segmentation 2012 and 2013 (US$ billion)
Exhibit 21: Merck & Co. Inc.: Revenue by Geographical Segmentation 2013


【レポート販売概要】

■ タイトル:グローバル・多嚢胞性卵巣症候群(PCOS)治療薬市場動向(2014-2018)
■ 英文:Global PCOS Drugs Market 2014-2018
■ 発行日:2014年4月25日
■ 調査会社:Technavio
■ 商品コード:IRTNTR3490
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。